Walgreens Boots Alliance reported a decrease in earnings per share to 33 cents in the fiscal third quarter, compared with $1.38 in the year-ago quarter. Adjusted earnings per share came in at 96 cents, surpassing analysts’ expectations of 92 cents per share.
The pharmacy retail company’s sales from continuing operations decreased -4.2 percent from the year-ago quarter to $32.6 billion. The company reported a $683 million charge related to its opioid settlement with the State of Florida in the current quarter.
In the U.K., Boots’ comparable sales climbed +24 percent, indicating some recovery in footfall, although store footfall remains around 20 percent below pre-Covid levels.
The Moving Average Convergence Divergence (MACD) for WBA turned positive on June 30, 2025. Looking at past instances where WBA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on WBA as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WBA advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 115 cases where WBA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
WBA broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.250) is normal, around the industry mean (3.463). P/E Ratio (32.848) is within average values for comparable stocks, (181.246). Projected Growth (PEG Ratio) (2.170) is also within normal values, averaging (1.915). Dividend Yield (0.086) settles around the average of (0.050) among similar stocks. P/S Ratio (0.117) is also within normal values, averaging (0.903).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. WBA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WBA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of drug store services
Industry DrugstoreChains